Katina Dorton
Board Member
TScan Therapeutics, Inc. (TCRX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Katina Dorton
Katina Dorton is recorded as Board Member at TScan Therapeutics, Inc. (TCRX). TScan Therapeutics, Inc. reported in an 8-K filed June 16, 2023 that Katina Dorton was appointed Nominating and Corporate Governance Committee member, effective June 13, 2023.
“the Company's Board of Directors also appointed Gabriela Gruia to the Audit Committee, Barbara Klencke to the Compensation Committee and Katina Dorton to the Nominating and Corporate Governance Committee, in each case to replace Timothy Barberich, effective as of June 13, 2023.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2021-01-01–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at TScan Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Gavin MacBeath CEO, CFO
- Stephen Biggar Chairman
- Jason A. Amello Chief Accounting Officer, Board Member
- Leiden Dworak Chief Accounting Officer
- Barbara Klencke, M.D. Board Member
- Chrystal Louis Board Member
- Garry A. Nicholson Board Member
- R. Keith Woods Board Member
- Zoran Zdraveski Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.